VION Biosciences Acquires Second Company in August 2024
VION Biosciences announced on August 29 its second transaction of the month with the acquisition of Texas-based Ansh Labs. Earlier in the month, VION acquired Echelon Biosciences, a Salt Lake City-based company that specializes in producing high-quality reagents and assays for the life sciences research community. The Ansh acquisition alongside the Echelon Biosciences acquisition, as well as the August 2023 acquisition of Aldon Corporation brings VION’s employee roster to nearly 100 employees. Ansh Labs is a Texas-based company that focuses on the development, production and distribution of high-quality immunoassay kits and reagents for research and clinical diagnostics. The... Read More »
Baxter Sells Kidney Care Segment to Carlyle for $3.5 Billion in Cash
Baxter International Inc. and funds managed by global investment firm The Carlyle Group announced on August 13 that they have signed a definitive agreement under which Carlyle will acquire the kidney-care unit of Baxter International. The unit will be named Vantive. The deal establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources. Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. The company’s products, digital... Read More »
OhioHealth Sells Outreach Laboratory Services Business to Quest Diagnostics
OhioHealth, based in Columbus, Ohio, announced on July 10 that it had signed an agreement to sell certain assets of its outreach laboratory services business to Quest Diagnostics. OhioHealth is a family of not-for-profit hospitals and healthcare facilities serving central Ohio since 1891. Quest Diagnostics provides diagnostic testing information services in the United States and internationally. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States with approximately 50,000 employees. According to its most recent annual report, Quest Diagnostics generated $9.25 billion in annual revenues during FY 2023, and annual EBITDA of $1.7... Read More »
PE-Backed I-MED Enters U.S. Market With Teleradiology Acquisition
Private equity-backed I-MED Radiology Network announced on July 2 that it is entering the U.S. market with the acquisition of San Diego-based teleradiology group StatRad. Founded in 1995, StatRad bills itself as the second largest teleradiology provider in the States. Privately owned by radiologists, StatRad employs more than 90 United States-based physicians performing reads for hundreds of clients and thousands of patients every day, according to its website. I-MED Radiology Network is one of Australia’s leading radiology providers, employing 450 doctors and operating 250 clinics located across Australia. Currently, teleradiology accounts for about 10% of I-MED’s revenue, with its... Read More »
Versant Diagnostics Advances Access to Pathology in the Midwest
Versant Diagnostics has announced the acquisition of Associate Pathologists of Joliet, Ltd., expanding its nationwide network of pathology practices and increasing its presence in the Midwest. Led by its president, pathologist James Urban, M.D., Ph.D., Associate Pathologists of Joliet is a multi-specialty pathology practice based in Joliet, Illinois. Founded in 2021 by Ven Aduana, M.D., Jim Billington and Brian Carr, Versant Diagnostics is an independent physician services company focused on anatomic pathology. Versant Diagnostics provides services for hospitals and physician practices. Versant Diagnostics is focused on advancing digital pathology in anatomic pathology labs and specialty... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
